AI assistant
Medicus Pharma Ltd. — Director's Dealing 2024
Dec 31, 2024
34562_dirs_2024-12-31_6c4e089e-116f-4fc7-88cb-bcbfcd4e4244.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2024-12-31
Reporting Person: Raju Ajay (10% Owner)
Reporting Person: 215 Capital TOGO PHL Fund I, LP (10% Owner)
Reporting Person: Togo PHL Management LLC (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 2000000 | Indirect |
Footnotes
F1: The shares are held of record by 215 Capital Togo PHL Fund I, LP ("215 Capital"). Togo PHL Management LLC (the "Management Company") has been delegated the responsibilities of the general partner of 215 Capital, Togo PHL Fund I GP, LLC, including the voting and dispositive power over the shares reported herein. Mr. Ajay Raju is responsible for managing the affairs of the Management Company including the voting and dispositive power over the shares reported herein. Mr. Raju therefore may be deemed to have voting and dispositive power over the shares reported herein.